AI-generated summary
The authors studied whether photobiomodulation affected oral lesions in rats given the carcinogen 4NQO for 12 or 20 weeks. They report that the light treatment did not change lesion development or the expression of p53 and ROS1 proteins compared with controls. Histopathology showed dysplasia at 12 weeks and mostly squamous cell carcinoma at 20 weeks, and the authors frame their findings as safety-related.
- Participants
- 66
- Who or what was studied
- Wistar rats receiving systemic 4NQO for 12 or 20 weeks, divided into control, PBM 0.3 J, and PBM 1 J groups
- Limits stated in the abstract
- The study used an animal model and the abstract does not report wavelengths, so its findings may not transfer directly to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on nature.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Total energy
- 0.3 J, 1 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Reactive oxygen species, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.